Lewy Bodies Contain Altered α-Synuclein in Brains of Many Familial Alzheimer's Disease Patients with Mutations in Presenilin and Amyloid Precursor Protein Genes

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915

α-Synuclein in Lewy bodies

Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop

McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960

AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836

Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections.

Shi, S., Key, M. E., & Kalra, K. L. (1991) · Journal of Histochemistry & Cytochemistry · doi:10.1177/39.6.1709656 · Cited by 2,543

Staging of alzheimer's disease-related neurofibrillary changes

Braak, H., & Braak, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00021-6 · Cited by 2,357

Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein

De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F. (1998) · Nature · doi:10.1038/34910 · Cited by 1,818

Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

(1998) · Europe PMC (PubMed Central) · Cited by 1,594

Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease

HYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542

A familial missense variant in the Alzheimer’s disease gene SORL1 impairs its maturation and endosomal sorting

Fazeli, E., Child, D. D., Bucks, S. A., Stovarsky, M., Edwards, G., Rose, S. E., Yu, C.-E., Latimer, C., Kitago, Y., Bird, T., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-023-02670-1 · Cited by 29

Osteoporosis and Dementia: Establishing a Link

Lary, C. W., Rosen, C. J., & Kiel, D. P. (2021) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4431 · Cited by 31

Neuroproteomics as a promising tool in Parkinson’s disease research

Pienaar, I. S., Daniels, W. M. U., & Götz, J. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0070-3 · Cited by 32

A Tangled Web – Tau and Sporadic Parkinson's Disease

Wray, S., & Lewis, P. A. (2010) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2010.00150 · Cited by 31

Alpha-synuclein: between synaptic function and dysfunction.

Rosa, G. D., Puzzo, D., Sant'Angelo, A., Trinchese, F., & Arancio, O. (2003) · PubMed · doi:10.14670/hh-18.1257 · Cited by 31

Phospho-HDAC6 Gathers Into Protein Aggregates in Parkinson’s Disease and Atypical Parkinsonisms

Mazzetti, S., Leonardis, M. D., Gagliardi, G., Calogero, A. M., Basellini, M. J., Madaschi, L., Costa, I., Cacciatore, F., Spinello, S., Bramerio, M., et al. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00624 · Cited by 30

Mixed multiple system atrophy and progressive supranuclear palsy: a clinical and pathological report of one case

Takanashi, M., Ohta, S., Matsuoka, S., Mori, H., & Mizuno, Y. (2001) · Acta Neuropathologica · doi:10.1007/s004010100433 · Cited by 30

Variability and heterogeneity in Alzheimer's disease with cotton wool plaques: a clinicopathological study of four autopsy cases

Yokota, O., Terada, S., Ishizu, H., Ujike, H., Ishihara, T., Namba, M., Hayashi, Y., Nishinaka, T., Namba, R., Nakashima, H., et al. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0737-7 · Cited by 30

Family history of dementia is a risk factor for Lewy body disease

Woodruff, B. K., Graff‐Radford, N. R., Ferman, T. J., Dickson, D. W., DeLucia, M. W., Crook, J. E., Arvanitakis, Z., Brassler, S., Waters, C., Barker, W., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000219812.20616.b3 · Cited by 31

A microtubule stabilizer ameliorates protein pathogenesis and neurodegeneration in mouse models of repetitive traumatic brain injury

Zhao, X., Zeng, W., Xu, H. W., Sun, Z., Hu, Y., Peng, B., McBride, J. D., Duan, J., Deng, J., Zhang, B., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abo6889 · Cited by 31

Microglia-driven inflammation induces progressive tauopathies and synucleinopathies

Lee, S. H., Bae, E.-J., Park, S. J., & Lee, S. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01450-z · Cited by 31

Effects of single and combined immunotherapy approach targeting amyloid β protein and α‐synuclein in a dementia with Lewy bodies–like model

Mandler, M., Rockenstein, E. M., Overk, C., Mante, M., Florio, J. B., Adame, A., Kim, C., Santic, R., Schneeberger, A., Mattner, F., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.02.002 · Cited by 29

Brain pathology in three subjects from the same pedigree with presenilin-1 (PSEN1) P264L mutation

Martikainen, P., Pikkarainen, M., Pöntynen, K., Hiltunen, M. O., Lehtovirta, M., Tuisku, S., Soininen, H. S., & Alafuzoff, I. I. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2009.01046.x · Cited by 28

α-Synuclein aggregation in pathological aging and Alzheimer's disease: The impact of ß-amyloid plaque level

Lippa, S. M., Lippa, C. F., & Mori, H. (2005) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750502000506 · Cited by 29

Dementia with Lewy Bodies and Parkinson's Disease Dementia

Ince, P. G. (2011) · Wiley eBooks · doi:10.1002/9781444341256.ch22 · Cited by 29

Single-nucleus RNA sequencing demonstrates an autosomal dominant Alzheimer’s disease profile and possible mechanisms of disease protection

Almeida, M. C., Eger, S. J., He, C., Audouard, M., Nikitina, A. A., Glasauer, S. M. K., Han, D., Mejía‐Cupajita, B., Acosta‐Uribe, J., Villalba‐Moreno, N. D., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.02.009 · Cited by 34

Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer’s disease, mild cognitive impairment, or healthy controls: a two year follow-up study

Berge, G., Sando, S. B., Albrektsen, G., Lauridsen, C., Møller, I., Grøntvedt, G. R., Bråthen, G., & White, L. R. (2016) · BMC Neurology · doi:10.1186/s12883-016-0706-0 · Cited by 29

Functional role of TGFβ in Alzheimer's disease microvascular injury: lessons from transgenic mice

Masliah, E., Ho, G. J., & Wyss‐Coray, T. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00046-8 · Cited by 28

Synucleinopathies: a pathological and molecular review

Murray, I. V. J., Lee, V. M. ‐., & Trojanowski, J. Q. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(01)00023-8 · Cited by 28

Alpha-synuclein is not a requisite component of synaptic boutons in the adult human central nervous system

Braak, H., Tredici, K. D., Gai, W., & Braak, E. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00101-0 · Cited by 28

Controversy: Is Parkinson's disease a single disease entity? Yes

Takahashi, H., & Wakabayashi, K. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.02.011 · Cited by 29

PS1 Alzheimer’s disease family with spastic paraplegia

Rogaeva, E. A., Bergeron, C., Sato, C., Moliaka, I., Kawarai, T., Toulina, A., Song, Y., Kolesnikova, T. D., Orlacchio, A., Bernardi, G., et al. (2003) · Neurology · doi:10.1212/wnl.61.7.1005 · Cited by 28

In vivo detection of Alzheimer's and Lewy body disease concurrence: Clinical implications and future perspectives

Baiardi, S., Hansson, O., Levin, J., & Parchi, P. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14039 · Cited by 27

Collusion of α-Synuclein and Aβ aggravating co-morbidities in a novel prion-type mouse model

Lloyd, G. M., Dhillon, J.-K. S., Gorion, K.-M. M., Riffe, C. J., Fromholt, S., Xia, Y., Giasson, B. I., & Borchelt, D. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00486-9 · Cited by 29

Genetic screening in early-onset Alzheimer's disease identified three novel presenilin mutations

Wong, T. H., Seelaar, H., Melhem, S., Rozemüller, A. J. M., & Swieten, J. C. V. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.01.015 · Cited by 27

Pick's disease: α- and β-synuclein-immunoreactive Pick bodies in the dentate gyrus

Mori, F., Hayashi, S., Yamagishi, S., Yoshimoto, M., Yagihashi, S., Takahashi, H., & Wakabayashi, K. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0578-9 · Cited by 27

A novel highly pathogenic Alzheimer presenilin-1 mutation in codon 117 (Pro117Ser): Comparison of clinical, neuropathological and cell culture phenotypes of Pro117Leu and Pro117Ser mutations

Dowjat, W. K., Kuchna, I., Wısnıewskı, T., & Węgiel, J. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6105 · Cited by 27

Role of tau versus TDP‐43 pathology on medial temporal lobe atrophy in aging and Alzheimer's disease

Wisse, L. E. M., Wuestefeld, A., Murray, M. E., Jagust, W. J., & Joie, R. L. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14582 · Cited by 24

Let’s make microglia great again in neurodegenerative disorders

Guillot‐Sestier, M., & Town, T. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1792-x · Cited by 26

Navigating the dynamic landscape of alpha-synuclein morphology: a review of the physiologically relevant tetrameric conformation

Lucas, H. R., & Fernández, R. D. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.265792 · Cited by 30

Mapping of Rat Brain Using the Synuclein-1 Monoclonal Antibody Reveals Somatodendritic Expression of α-Synuclein in Populations of Neurons Homologous to those Vulnerable to Lewy Body Formation in Human Synucleopathies

Andringa, G., Du, F., Chase, T. N., & Bennett, M. C. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.10.1060 · Cited by 26

Enhanced accumulation of phosphorylated α‐synuclein in double transgenic mice expressing mutant β‐amyloid precursor protein and presenilin‐1

Kurata, T., Kawarabayashi, T., Murakami, T., Miyazaki, K., Morimoto, N., Ohta, Y., Takehisa, Y., Nagai, M., Ikeda, M., Matsubara, E., et al. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21352 · Cited by 26

Lewy body variant of Alzheimer’s disease or cerebral type Lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem

Yokota, O., Tsuchiya, K., Uchihara, T., Ujike, H., Terada, S., Takahashi, M., Kimura, Y., Ishizu, H., Akiyama, H., & Kuroda, S. (2007) · Neuropathology · doi:10.1111/j.1440-1789.2006.00736.x · Cited by 26

The genetic causes of neurodegenerative diseases

Hardy, J. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3115 · Cited by 26

Autopsy-Confirmed Familial Early-Onset Alzheimer Disease Caused by the L153V Presenilin 1 Mutation

Janssen, J. C., Lantos, P. L., Fox, N. C., Harvey, R. J., Beck, J. A., Dickinson, A., Campbell, T. A., Collinge, J., Hanger, D. P., Cipolotti, L., et al. (2001) · Archives of Neurology · doi:10.1001/archneur.58.6.953 · Cited by 26

α-Synuclein Preformed Fibrils Bind to β-Neurexins and Impair β-Neurexin-Mediated Presynaptic Organization

Feller, B., Fallon, A., Luo, W., Nguyen, P. T., Shlaifer, I., Lee, A. K., Chofflet, N., Yi, N., Khaled, H., Karkout, S., et al. (2023) · Cells · doi:10.3390/cells12071083 · Cited by 22

Impact of Pre-Analytical Differences on Biomarkers in the ADNI and PPMI Studies: Implications in the Era of Classifying Disease Based on Biomarkers

Stewart, T., Initiative, A. F. T. A. D. N., Shi, M. Y., Mehrotra, A., Aro, P., Soltys, D., Kerr, K. F., Zabetian, C. P., Peskind, E. R., Taylor, P., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190069 · Cited by 24

Lewy body pathology in late-onset familial Alzheimer's disease: A clinicopathological case series

Tsuang, D. W., Riekse, R. G., Purganan, K., David, A. C., Montine, T. J., Schellenberg, G. D., Steinbart, E. J., Petrie, E. C., Bird, T. D., & Leverenz, J. B. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9302 · Cited by 24

Pathological substrate of dementia in Parkinson's disease—its relation to DLB and DLBD

Mori, H. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.02.012 · Cited by 24

CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders

Baier, A., & Szyszka, R. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.916063 · Cited by 23

The genetics of neurodegenerative diseases is the genetics of age-related damage clearance failure

Hardy, J., & Escott‐Price, V. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02911-7 · Cited by 25

Alpha-Synuclein Accumulation and Its Phosphorylation in the Enteric Nervous System of Patients Without Neurodegeneration: An Explorative Study

Bu, L.-L., Huang, K., Zheng, D., Lin, D., Chen, Y., Jing, X., Liang, Y., & Tao, E. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.575481 · Cited by 24

Alpha-synuclein Levels in the Differential Diagnosis of Lewy Bodies Dementia and Other Neurodegenerative Disorders

Mavroudis, I. A., Petridis, F., Chatzikonstantinou, S., & Kazis, D. A. (2020) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000381 · Cited by 25

Monitoring the interactions between alpha-synuclein and Tau in vitro and in vivo using bimolecular fluorescence complementation

Torres-Garcia, L., Domingues, J. M. P., Brandi, E., Haikal, C., Mudannayake, J. M., Brás, I. C., Gerhardt, E., Li, W., Svanbergsson, A., Outeiro, T. F., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-06846-9 · Cited by 21

Casein Kinase 1δ Inhibitors as Promising Therapeutic Agents for Neurodegenerative Disorders

Catarzi, D., Varano, F., Vigiani, E., Lambertucci, C., Spinaci, A., Volpini, R., & Colotta, V. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220301115124 · Cited by 24

Cross-talk between α-synuclein and the microtubule cytoskeleton in neurodegeneration

Mazzetti, S., Calogero, A. M., Pezzoli, G., & Cappelletti, G. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114251 · Cited by 22

The clinical importance of suspected non-Alzheimer disease pathophysiology

Vos, S. J. B., Delvenne, A., Jack, C. R., Thal, D. R., & Visser, P. J. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00962-y · Cited by 23

Dementia with Lewy bodies

Leverenz, J. B., & McKeith, I. G. (2002) · Medical Clinics of North America · doi:10.1016/s0025-7125(02)00012-3 · Cited by 22

Relationship between Parkinson disease with dementia and dementia with Lewy bodies

Guo, L., Itaya, M., Takanashi, M., Mizuno, Y., & Mori, H. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.02.005 · Cited by 21

The Relationship between Lewy Body Disease, Parkinson's Disease, and Alzheimer's Disease

Hardy, J. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07474.x · Cited by 21

Dementia with Lewy Bodies

Ince, P. G. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1249-3_12 · Cited by 21

Navigating through the complexities of synucleinopathies: Insights into pathogenesis, heterogeneity, and future perspectives

Lázaro, D. F., & Lee, V. M. ‐. (2024) · Neuron · doi:10.1016/j.neuron.2024.05.017 · Cited by 20

α-Synuclein Pathology in the Amyotrophic Lateral Sclerosis/Parkinsonism Dementia Complex in the Kii Peninsula, Japan

Kokubo, Y., Taniguchi, A., Hasegawa, M., Hayakawa, Y., Morimoto, S., Yoneda, M., Hirokawa, Y., Shiraishi, T., Saito, Y., Murayama, S., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825b9680 · Cited by 19

Phosphorylation and oligomerization of α-synuclein associated with GSK-3β activation in the rTg4510 mouse model of tauopathy

Takaichi, Y., CHAMBERS, J. K., Inoue, H., Ano, Y., Takashima, A., Nakayama, H., & Uchida, K. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00969-8 · Cited by 20

Deciphering the Interacting Mechanisms of Circadian Disruption and Alzheimer’s Disease

Uddin, M. S., Sumsuzzman, D. M., Jeandet, P., Behl, T., Rauf, A., Amran, M. S., & Ashraf, G. M. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03325-x · Cited by 23

Neurodegenerative disease: a different view of diagnosis

Hardy, J., & Gwinn, K. A. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01604-4 · Cited by 20

Neurofilament-Rich Intraneuronal Inclusions Exacerbate Neurodegenerative Sequelae of Brain Trauma in NFH/LacZ Transgenic Mice

Galvin, J. E., Nakamura, M., McIntosh, T. K., Saatman, K. E., Sampathu, D. M., Raghupathi, R., Lee, V. M. ‐., & Trojanowski, J. Q. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7461 · Cited by 20

Dementia with Lewy bodies in Down's syndrome

Simard, M., & van Reekum, R. (2001) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.342 · Cited by 20

Effects of Alzheimer and Lewy Body Disease Pathologies on Brain Metabolism

Lee, Y., Jeon, S., Park, M.-C., Kang, S. W., Yoon, S. H., Baik, K., Lee, P. H., Sohn, Y. H., Ye, B. S., & Initiative, T. A. D. N. (2022) · Annals of Neurology · doi:10.1002/ana.26355 · Cited by 19

Cerebrospinal fluid levels of phosphorylated tau and Aβ1-38/Aβ1-40/Aβ1-42 in Alzheimer’s disease with PS1 mutations

Ikeda, M., Yonemura, K., Kakuda, S., Tashiro, Y., Fujita, Y., Takai, E., Hashimoto, Y., Makioka, K., Furuta, N., Ishiguro, K., et al. (2013) · Amyloid · doi:10.3109/13506129.2013.790810 · Cited by 19

Novel PSEN1 Mutation in a Bulgarian Patient With Very Early-Onset Alzheimer’s Disease, Spastic Paraparesis, and Extrapyramidal Signs

Traykov, L. D., Mehrabian, S., den Broeck, M. V., Raycheva, M. R., Cruts, M., Jordanova, A., & Broeckhoven, C. V. (2009) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317509341464 · Cited by 20

Proteome Response to the Panneural Expression of Human Wild-Type α-Synuclein: A Drosophila Model of Parkinson’s Disease

Xun, Z., Kaufman, T. C., & Clemmer, D. E. (2008) · Journal of Proteome Research · doi:10.1021/pr800207h · Cited by 19

Neurodegenerative Diseases: Pathology and the Advantage of Single-Cell Profiling

Galvin, J. E. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000023592.53769.4d · Cited by 18

Formation of Heterotypic Amyloids: α‐Synuclein in Co‐Aggregation

Bhasne, K., & Mukhopadhyay, S. (2018) · PROTEOMICS · doi:10.1002/pmic.201800059 · Cited by 17

Alzheimer's disease and related dementias

Hardy, J. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139087711.003 · Cited by 18

β-Synuclein-Derived Peptides With Neuroprotective Activity: An Alternative Treatment of Neurodegenerative Disorders?

Windisch, M., Hutter‐Paier, B., Schreiner, E., & Wronski, R. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:1:155 · Cited by 18

α‐Synuclein‐positive structures in association with diffuse neurofibrillary tangles with calcification

Hishikawa, N., Hashizume, Y., Ujihira, N., Okada, Y., Yoshida, M., & Sobue, G. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2003.00470.x · Cited by 18

Amygdala-predominant α-synuclein pathology is associated with exacerbated hippocampal neuron loss in Alzheimer’s disease

Gawor, K., Tomé, S. O., Vandenberghe, R. R., Damme, P. V., Vandenbulcke, M., Otto, M., Arnim, C. A. F. V., Ghebremedhin, E., Ronisz, A., Ospitalieri, S., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae442 · Cited by 22

Monoamine oxidase and α-synuclein as targets in Parkinson’s disease therapy

Follmer, C. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.920235 · Cited by 18

Defective Lysosomal Lipid Catabolism as a Common Pathogenic Mechanism for Dementia

Lee, J. Y., Marian, O. C., & Don, A. S. (2021) · NeuroMolecular Medicine · doi:10.1007/s12017-021-08644-4 · Cited by 18

Génétique de la maladie d’Alzheimer : formes autosomiques dominantes

Guyant‐Maréchal, L., Campion, D., & Hannequin, D. (2008) · Revue Neurologique · doi:10.1016/j.neurol.2008.10.019 · Cited by 20

Synuclein aggregation: possible role in traumatic brain injury

Bramlett, H. M., & Dietrich, W. D. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00401-1 · Cited by 17

Recent advances in the genetics of dementia with Lewy bodies

Bonifati, V. (2008) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-008-0030-1 · Cited by 16

Early oligomerization stages for the non-amyloid component of α-synuclein amyloid

Eugene, C., Laghaei, R., & Mousseau, N. (2014) · The Journal of Chemical Physics · doi:10.1063/1.4896381 · Cited by 16

The complex relationship between genotype, pathology and phenotype in familial dementia

Kwok, J. B., Loy, C. T., Dobson‐Stone, C., & Halliday, G. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105082 · Cited by 17

Familial Lewy Body Diseases

Gwinn, K. A., & Singleton, A. (2002) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198870201500407 · Cited by 16

Alpha-synuclein deposition patterns in Alzheimer’s disease: association with cortical amyloid beta and variable tau load

Neubauer, A., Weissenbrunner, D., Pekrun, S., Roeber, S., Ruf, V. C., Feyen, P. L. C., Strübing, F., & Herms, J. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02952-w · Cited by 17

I716F AβPP Mutation Associates with the Deposition of Oligomeric Pyroglutamate Amyloid-β and α-Synucleinopathy with Lewy Bodies

Berger–Sieczkowski, E., Milenković, I., Venkataramani, V., Giera, R., Ströbel, T., Höftberger, R., Liberski, P. P., Auff, E., Wirths, O., Bayer, T. A., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141524 · Cited by 16

Synphilin-1-Binding Protein NUB1 is Colocalized With Nonfibrillar, Proteinase K-Resistant α-Synuclein in Presynapses in Lewy Body Disease

Tanji, K., Mori, F., Kito, K., Kakita, A., Mimura, J., Itoh, K., Takahashi, H., Kamitani, T., & Wakabayashi, K. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182303745 · Cited by 16

Modelling the functional genomics of Parkinson’s disease inCaenorhabditis elegans:LRRK2and beyond

Chandler, R. J., Cogo, S., Lewis, P. A., & Kevei, É. (2021) · Bioscience Reports · doi:10.1042/bsr20203672 · Cited by 16

Comparison of α-synuclein immunoreactivity and protein levels in ischemic hippocampal CA1 region between adult and aged gerbils and correlation with Cu,Zn-superoxide dismutase

Yoon, D.-K., Hwang, I. K., Yoo, K., Lee, Y.-B., Lee, J.-J., Kim, J., Kang, T., Lee, B., Sohn, H.-S., & Won, M. H. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.04.014 · Cited by 15

Concomitant accumulation of α-synuclein and TDP-43 in a patient with corticobasal degeneration

Yamashita, S., Sakashita, N., Yamashita, T., Tawara, N., Tasaki, M., Kawakami, K., Komohara, Y., Fujiwara, Y., Kamikawa, M., Nakagawa, T., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7491-8 · Cited by 16

Lewy bodies and dementia

Galasko, D. (2001) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-001-0103-x · Cited by 15

Editorial: Protein Misfolding and Spreading Pathology in Neurodegenerative Diseases

Lázaro, D. F., Bellucci, A., Brundin, P., & Outeiro, T. F. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00312 · Cited by 15

Genetic Complexity of Early-Onset Alzheimer’s Disease

Ghani, M., Reitz, C., George‐Hyslop, P. S., & Rogaeva, E. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-72938-1_3 · Cited by 15

Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease

Diaw, S. H., Borsche, M., Streubel-Gallasch, L., Dulovic‐Mahlow, M., Hermes, J., Lenz, I., Seibler, P., Klein, C., Brüggemann, N., Vos, M. H., et al. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00584-z · Cited by 14

α-Synuclein and tau, two targets for dementia

Silva, M., Caro, V., Guzmán, C., Perry, G. L., Areche, C., & Cornejo, A. (2020) · Studies in natural products chemistry · doi:10.1016/b978-0-12-819483-6.00001-1 · Cited by 15

Cell-free amplification of prions: Where do we stand?

Cazzaniga, F. A., Luca, C. M. G. D., Bistaffa, E., Consonni, A., Legname, G., Giaccone, G., & Moda, F. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.08.005 · Cited by 14

Secondary Chemical Bonding between Insoluble Calcium Oxalate and Carbonyl Oxygen Atoms of GLY and VAL Residues Triggers the Formation of Aβ Aggregates and Their Deposition in the Brain

Zhang, X., Ma, X., Gan, T., Shi, Y., Wang, Y., & Liu, Q. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00662 · Cited by 14

Gene expression profile in Alzheimer’s brain screened by molecular indexing

Doyu, M., Sawada, K.-I., Mitsuma, N., Niwa, J., Yoshimoto, M., Fujii, Y., Sobue, G., & Kato, K. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00223-0 · Cited by 14

A multigenerational pedigree of late-onset Alzheimer's disease implies new genetic causes

Jiménez‐Escrig, A., Gómez‐Tortosa, E., Baron, M., Rábano, A., Arcos‐Burgos, M., Palacio, L. G., Yusta, A., Anta, P., Perez, I., Hierro, M., et al. (2005) · Brain · doi:10.1093/brain/awh501 · Cited by 14

Hepta-Histidine Inhibits Tau Aggregation

Kondo, K., Ikura, T., Tanaka, H., Fujita, K., Takayama, S., Yoshioka, Y., Tagawa, K., Homma, H., Liu, S., Kawasaki, R., et al. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00164 · Cited by 12

Dementia With Lewy Bodies in a Nigerian: A Case Report

Ogunniyi, A. O., Akang, E. E. U., Gureje, O., Baiyewu, O., Takao, M., Piccardo, P., Ghetti, B. F., Hall, K. S., & Hendrie, H. C. (2002) · International Psychogeriatrics · doi:10.1017/s1041610202008402 · Cited by 12

Current drugs and future hopes in the treatment of Alzheimer’s disease

Windisch, M., Hutter‐Paier, B., & Schreiner, E. (2002) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6139-5_15 · Cited by 12

Recruitment of Aβ into α-Synuclein Condensates Catalyzes Primary Nucleation of α-Synuclein Aggregation

Morris, O. M., Röntgen, A., Toprakcioglu, Z., Cali, M. P., Dada, S., & Vendruscolo, M. (2025) · ACS Central Science · doi:10.1021/acscentsci.5c00614 · Cited by 12

Disrupted metabolic connectivity in dopaminergic and cholinergic networks at different stages of dementia from 18F-FDG PET brain persistent homology network

Hsu, T., Fuh, J., Wang, D., Chen, L., Chang, C.-J., Huang, W.-S., Wu, H., & Guo, W. (2021) · Scientific Reports · doi:10.1038/s41598-021-84722-8 · Cited by 11

Elucidating distinct molecular signatures of Lewy body dementias

Harvey, J., Pishva, E., Chouliaras, L., & Lunnon, K. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106337 · Cited by 11

Clinicopathological correlations and cholinesterase expression in early-onset familial Alzheimer's disease with the presenilin 1 mutation, Leu235Pro

Cash, M. K., Rockwood, K. J., Fisk, J. D., & Darvesh, S. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.02.025 · Cited by 11

Possible Role of Amyloid Cross-Seeding in Evolvability and Neurodegenerative Disease

Hashimoto, M., Ho, G. J., Takamatsu, Y., Wada, R., Sugama, S., Takenouchi, T., Waragai, M., & Masliah, E. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-191675 · Cited by 12

Differential Regional Responses in Soluble Monomeric Alpha Synuclein Abundance Following Traumatic Brain Injury

Carlson, S. W., Yan, H. Q., Li, Y., Henchir, J. J., Ma, X., Young, M., Ikonomović, M. D., & Dixon, C. E. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02123-w · Cited by 11

Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

(1998) · Europe PMC (PubMed Central) · Cited by 1,594

Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease

Mezey, É., Dehejia, A. M., Harta, G., Suchy, S. F., Nussbaum, R. L., Brownstein, M. J., & Polymeropoulos, M. H. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000446 · Cited by 139

Purification of Lewy Bodies and Identification of α-Synuclein as a Major Component of Lewy Bodies

Iwatsubo, T., Baba, M., Lee, V. M., & Trojanowski, J. Q. (2000) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-662-04056-0_2 · Cited by 1

Synphilin-1 is present in Lewy bodies in Parkinson's disease

Wakabayashi, K., Engelender, S., Yoshimoto, M., Tsuji, S., Ross, C. A., & Takahashi, H. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4 · Cited by 269

Alpha‐synuclein in Lewy Body Disease and Alzheimer's Disease

Hashimoto, M., & Masliah, E. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00552.x · Cited by 254